Early diagnostic value of high‐sensitivity cardiac troponin T for cancer treatment‐related cardiac dysfunction: a meta‐analysis
Abstract Early diagnosis of cancer treatment‐related cardiac dysfunction (CTRCD) is important as cancer therapy increases the risk of cardiac dysfunction. High‐sensitivity cardiac troponin T (hs‐cTnT) is a highly specific marker of myocardial injury. However, its diagnostic value for CTRCD has not b...
Main Authors: | Xinfang Lv, ChenLiang Pan, Huan Guo, Juan Chang, Xiang Gao, Xue Wu, Xiaodong Zhi, Chunzhen Ren, Qilin Chen, Hugang Jiang, Xinke Zhao, Kai Liu, Yingdong Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.14373 |
Similar Items
-
Statins and highly sensitive cardiac troponins: cardiotoxicity or cross-reactivity?
by: A. M. Chaulin, et al.
Published: (2023-05-01) -
Development and validation of a nomogram to predict cardiac death after radiotherapy for esophageal cancer
by: Xinfang Lv, et al.
Published: (2023-10-01) -
Clinical Utility of Cardiac Troponin I and Cardiac Troponin T Measurements
by: Michaela Adamcová, et al.
Published: (1997-01-01) -
Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS‐ONE trial
by: Jennifer M.T.A. Meessen, et al.
Published: (2020-08-01) -
The Utility of Cardiac Reserve for the Early Detection of Cancer Treatment-Related Cardiac Dysfunction: A Comprehensive Overview
by: Stephen Foulkes, et al.
Published: (2020-03-01)